Abstract
Last December 2019, a cluster of viral pneumonia cases identified as coronavirus disease 2019 (COVID-19) was reported in Wuhan, China. We aimed to explore the frequencies of nasal symptoms in patients with COVID-19, including loss of smell and taste, as well as their presentation as the first symptom of the disease and their association with the severity of COVID-19. In this retrospective study, 1206 laboratory-confirmed COVID-19 patients were included and followed up by telephone one month after discharged from Tongji Hospital, Wuhan. Demographic data, laboratory values, comorbidities, symptoms, and numerical rating scale scores (0–10) of nasal symptoms were extracted from the hospital medical records, and confirmed or reevaluated by the telephone follow-up. From patients (n=1172) completing follow-up, 199 (17%) subjects had severe COVID-19 and 342 (29.2%) reported nasal symptoms. 20.6% COVID-19 patients had loss of taste (median score=6), while 11.4% had loss of smell (median score=5). Loss of taste scores, but not loss of smell scores, were significantly increased in severe vs. non-severe COVID-19 patients. Interleukin (IL)-6 and lactose dehydrogenase (LDH) serum levels were positively correlated with loss of taste scores. About 80% of COVID-19 patients recovered from smell and taste dysfunction in 2 weeks. In this cohort, only 1 out of 10 hospital admitted patients had loss of smell while 1 out of 5 reported loss of taste which was associated to severity of COVID-19. Most patients recovered smell and taste dysfunctions in 2 weeks.
Article PDF
Similar content being viewed by others
References
Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 2020,382(18):1708–1720
Giacomelli A, Pezzati L, Conti F, et al. Self-reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis, 2020,71(15):889–890
Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol, 2020,277(8):2251–2261
Yan CH, Faraji F, Prajapati DP, et al. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol, 2020,10(7):806–813
Roland LT, Gurrola JG, Loftus PA, et al. Smell and taste symptom-based predictive model for COVID-19 diagnosis. Int Forum Allergy Rhinol, 2020,10(7):832–838
Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol, 2020,77(6):683–690
WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. January 28, 2020 (https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf).
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med, 2019, 200(7):e45–e67
Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology, 2020,58(Suppl S29):1–464
Zeng M, Wang H, Liao B, et al. Comparison of efficacy of fluticasone propionate versus clarithromycin for postoperative treatment of different phenotypic chronic rhinosinusitis: a randomized controlled trial. Rhinology, 2019,57(2):101–109
Pellegrino R, Walliczek-Dworschak U, Winter G, et al. Investigation of chemosensitivity during and after an acute cold. Int Forum Allergy Rhinol, 2017,7(2):185–91
Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J, 2020,55(5)
Cheng L, Chen J, Fu Q, et al. Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. Allergy Asthma Immunol Res, 2018,10(4):300–353
Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities. Allergy, 2015,70(5):533–539
Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis, 2020, 71(15):762–768
Wang JH, Kwon HJ, Jang YJ. Detection of Parainfluenza Virus 3 in Turbinate Epithelial Cells of Postviral Olfactory Dysfunction Patients. Laryngoscope, 2007, 117(8):1445–1449
Suzuki M, Saito K, Min WP, et al. Identification of Viruses in Patients with Postviral Olfactory Dysfunction. The Laryngoscope, 2007,117(2):272–277
Malhotra P, Luka A, McWilliams CS, et al. Clinical Features of Respiratory Viral Infections Among Inpatients at a Major US Tertiary Care Hospital. South Med J, 2016,109(8):481–486
Luers JC, Rokohl AC, Loreck N, et al. Olfactory and Gustatory Dysfunction in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis, 2020,71(16):2262–2264
Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan, 2006,15(1):26–28
Hummel T, Landis BN, Huttenbrink KB. Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2011,10:Doc04
van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol, 2015,235(2):277–287
Baig AM, Khaleeq A, Ali U, et al. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci, 2020,11(7):995–998
Mullol J, Alobid I, Mariño-Sánchez F, et al. The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries. Curr Allergy Asthma Rep, 2020,20(10):61
Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist, 2020, 073858420956905
Cooper KW, Brann DH, Farruggia MC, et al. COVID-19 and the Chemical Senses: Supporting Players Take Center Stage. Neuron, 2020,107(2):219–233
Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol, 2008,82(15):7264–7275
Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci, 2020,12(1):8
Wu C, Zheng S, Chen Y, et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue. medRxiv, 2020, doi: https://doi.org/10.1101/2020.02.11.20022228
Kumarhia D, He L, McCluskey LP. Inflammatory stimuli acutely modulate peripheral taste function. J Neurophysiol, 2016,115(6):2964–2975
Henkin RI, Schmidt L, Velicu I. Interleukin 6 in Hyposmia. JAMA Otolaryngol Head Neck Surg, 2013,139(7):728–734
Soler ZM, Patel ZM, Turner JH, et al. A primer on viral-associated olfactory loss in the era of COVID-19. Int Forum Allergy Rhinol, 2020,10(7):814–820
Bousquet J, Akdis C, Jutel M, et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy, 2020, doi: https://doi.org/10.1111/011.14302
Acknowledgments
We thank to Cai-lin CHEN, Zhao-qin LIAN, Mengchen WANG, Jing-xian LI, Jing-xin LIU, Qiao XIAO, Si-tao HU, Chong-shu WANG, Yi-bo LIU, Jian-wen RUAN and Xue-li LI for their help with data collecting.
Author information
Authors and Affiliations
Corresponding authors
Additional information
This study was supported by grants from the Natural Science Foundation of Hubei Province of China (No. 2018CFB602), National Key R&D Program of China (No. 2018YFC0116800), and National Natural Science Foundation of China (Nos: 81630024, 81920108011, and 81900925).
Conflict of Interest Statement
The authors declare that they have no competing interests.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Song, J., Deng, Yk., Wang, H. et al. Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China. CURR MED SCI 41, 14–23 (2021). https://doi.org/10.1007/s11596-021-2312-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-021-2312-7